| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Another dopamine agonist for treatment of restless legs syndrome
|
Earley, Christopher J
|
|
2011
|
10 |
8 |
p. 675-677
3 p.
|
artikel
|
| 2 |
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study
|
Biffi, Alessandro
|
|
2011
|
10 |
8 |
p. 702-709
8 p.
|
artikel
|
| 3 |
Autoantibodies associated with diseases of the CNS: new developments and future challenges
|
Vincent, Angela
|
|
2011
|
10 |
8 |
p. 759-772
14 p.
|
artikel
|
| 4 |
Combining statins with interferon beta in multiple sclerosis: think twice, it might not be all right
|
Zamvil, Scott S
|
|
2011
|
10 |
8 |
p. 672-673
2 p.
|
artikel
|
| 5 |
CSF α-synuclein, tau, and amyloid β in Parkinson's disease
|
Shi, Min
|
|
2011
|
10 |
8 |
p. 681-
1 p.
|
artikel
|
| 6 |
CSF α-synuclein, tau, and amyloid β in Parkinson's disease – Authors' reply
|
Mollenhauer, Brit
|
|
2011
|
10 |
8 |
p. 681-683
3 p.
|
artikel
|
| 7 |
Erratum
|
|
|
2011
|
10 |
8 |
p. 680-
1 p.
|
artikel
|
| 8 |
Freezing of gait: moving forward on a mysterious clinical phenomenon
|
Nutt, John G
|
|
2011
|
10 |
8 |
p. 734-744
11 p.
|
artikel
|
| 9 |
Genetics of intracerebral haemorrhage: a tsunami effect of APOE ε2 genotype on brain bleeding size?
|
Montaner, Joan
|
|
2011
|
10 |
8 |
p. 673-675
3 p.
|
artikel
|
| 10 |
Jay Nutt: a boatman's calling
|
Holmes, David
|
|
2011
|
10 |
8 |
p. 686-
1 p.
|
artikel
|
| 11 |
Jonathan Rosand
|
|
|
2011
|
10 |
8 |
p. 687-
1 p.
|
artikel
|
| 12 |
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
|
Oertel, Wolfgang
|
|
2011
|
10 |
8 |
p. 710-720
11 p.
|
artikel
|
| 13 |
Mapping the brain: of mice and men
|
Holmes, David
|
|
2011
|
10 |
8 |
p. 684-685
2 p.
|
artikel
|
| 14 |
May, 2011
|
|
|
2011
|
10 |
8 |
p. 687-
1 p.
|
artikel
|
| 15 |
Mirrors and metaphors: secrets of the evolving brain
|
Brown, Rachel L
|
|
2011
|
10 |
8 |
p. 688-
1 p.
|
artikel
|
| 16 |
Natalizumab for multiple sclerosis: a complicated treatment
|
Keegan, B Mark
|
|
2011
|
10 |
8 |
p. 677-678
2 p.
|
artikel
|
| 17 |
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
|
Kappos, Ludwig
|
|
2011
|
10 |
8 |
p. 745-758
14 p.
|
artikel
|
| 18 |
News in brief
|
|
|
2011
|
10 |
8 |
p. 690-
1 p.
|
artikel
|
| 19 |
NIA funding for Alzheimer's research
|
Barr, Robin A
|
|
2011
|
10 |
8 |
p. 683-
1 p.
|
artikel
|
| 20 |
Novel platelet antiaggregants and the changing landscape of stroke prevention
|
Goldstein, Larry B
|
|
2011
|
10 |
8 |
p. 678-680
3 p.
|
artikel
|
| 21 |
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
|
Sorensen, Per Soelberg
|
|
2011
|
10 |
8 |
p. 691-701
11 p.
|
artikel
|
| 22 |
The importance of aetiology in epilepsy
|
Camfield, Peter
|
|
2011
|
10 |
8 |
p. 688-689
2 p.
|
artikel
|
| 23 |
The monoamine neurotransmitter disorders: an expanding range of neurological syndromes
|
Kurian, Manju A
|
|
2011
|
10 |
8 |
p. 721-733
13 p.
|
artikel
|
| 24 |
UK neurological care: time to confront the crisis
|
The Lancet Neurology,
|
|
2011
|
10 |
8 |
p. 671-
1 p.
|
artikel
|
| 25 |
Understanding demyelinating disorders of childhood
|
Brinar, Vesna V
|
|
2011
|
10 |
8 |
p. 689-
1 p.
|
artikel
|
Tijdschrift beschrijving